期刊文献+

SSTR1~3亚型蛋白在大肠癌组织中的表达及临床意义 被引量:4

Expression of somatostatin receptor subtypes 1-3 in colorectal carcinoma
原文传递
导出
摘要 目的:探讨生长抑素受体(SSTR)1~3亚型蛋白在大肠癌组织中表达及其与临床病理学的关系。方法:收集41例大肠癌患者手术切除肿瘤组织标本及23例远癌组织(指距肿瘤活检切除边缘3~6 cm的组织)标本,采用免疫组化PV-9000二步法检测其SSTR1~3亚型蛋白的表达;采用Fisher确切概率法进行统计学分析,并分析与临床相关因素的关系。结果:41例大肠癌组织中SSTR1~3亚型蛋白的阳性表达率分别为65.8%(27/41)、61.0%(25/41)和56.1%(23/41),均较远癌组织表达率低(P<0.05)。SSTR1~3亚型蛋白在大肠癌组织中的表达与患者的性别、有无淋巴结转移和临床分期无关,SSTR2和SSTR3亚型蛋白与肿瘤的分化程度及肿瘤的部位无关;而SSTR1亚型蛋白在高/高中分化的大肠癌组织中的表达高于低中分化和低分化大肠癌组织中的表达,且直肠癌中的表达较结肠癌低(P<0.05)。结论:SSTR1亚型蛋白是大肠癌组织中的主要表达形式,可能与大肠癌的发生发展有关。 Objective: To investigate the SSTR subtypes expression and distribution in tissues of colorectal carcinoma and relationship with their clinicopathological feature. Methods: The total 41 cases of colorectal carcinoma tissues and their adjacent tissues (23 cases) were involved in this study at random. The expression of SSTR1-3 subtype proteins in 41 cases of the colorectal carcinoma tissues were detected by immunohistochemistry used by two-step way. The expressions of SSTR1-3 subtype proteins and clinical pathology were analyzed with Fisher's exact probabilities method and Spearman's non-parametric analysis. Results: The expression levels of SSTR1-3 subtype proteins in the colorectal carcinoma tissues were 65.8% (27/41) ,61.0% (25/41) and 56. 1% (23/41) respectively, which showed that the expressions of SSTR1-3 subtype proteins were significantly lower than that in adjacent normal colorectal carcinoma tissues (P 〈 0. 05 ). It also showed that the expressions of SSTR1-3 subtype proteins were not correlated with gender, TNM staging and metastasis, and the expression of SSTR1 in high differentiated tissues was significantly higher than poorly differentiated tissues. Conclusion: SSTR1 subtype protein is the main expression pattern in colorectal carcinoma and it may be closely related with development and genesis of colorectal carcinoma.
出处 《现代医学》 2012年第6期645-648,共4页 Modern Medical Journal
关键词 大肠癌 生长抑素 生长抑素受体 免疫组织化学 colorectal carcinoma somatostatin somatostatin receptor immunohistochemistry
  • 相关文献

参考文献8

  • 1KWEKKEBOOM D J, KRENNING E P. Somatostatin receptor imaging[ J]. Semin Nucl Med,2002,32(2) :84-91.
  • 2HOFLAND L J, LAMBERTS S W. Somatostatin receptor sub- type expression in human tumors [ J ]. Ann Oncol, 2001,12 ( suppl 2) :S31-36.
  • 3PATAL Y C, GREEN-WORD M T, PANETYA R, et al. Minire- view the somatostatin receptor family [ J ]. Life Sciences, 1998, 57 ( 13 ) : 1249-1265.
  • 4张喜梅,黄介飞,张弘,魏群,沈卫东.肝癌生长抑素受体mRNA表达的研究[J].中华肝脏病杂志,2006,14(5):383-384. 被引量:3
  • 5潘骅,张弘,黄介飞,魏群.生长抑素受体1~3亚型蛋白在胃癌中的表达及临床意义[J].胃肠病学和肝病学杂志,2008,17(10):826-828. 被引量:2
  • 6DENZLER B, REUBI J C. Expression of somatostatin receptors in peripheral veins of human tumors [ J ]. Cancer, 1999,85 (1) :188-198.
  • 7CARCIA- de-la-TORRE N, WASS J A, TURNER H E. Antian- giogenic effects of somatostatin analogues [ J ]. Clin Endocrinol ( Oxf), 2002,57 ( 4 ) :425-441.
  • 8SHIMON I. Somatostatin receptors in pituitary and develop- ment of somatostatin receptor subtype- selective analogs [ J ]. Endocrine,2003,20(3) :265-269.

二级参考文献10

  • 1呼闯营,易粹琼.生长抑素受体SSTR3基因对胃癌细胞生长的影响[J].临床消化病杂志,2005,17(6):282-285. 被引量:4
  • 2Kwekkeboom D J, Krenning EP. Somatostatin receptor imaging [ J]. Semin Nucl Med, 2002, 32(2):84-91.
  • 3Hofland LJ, Lamberts SW. Somatostatin receptor subtype expression in human tumors [J]. Ann Oneol, 2001, 12(Suppl 2): S31-36.
  • 4Grant MB, Caballero S. Somatostatin analogues as drug therapies for retinopathies [J]. Drugs Today (Barc), 2002, 38(11): 783-791.
  • 5Komatsuzaki K, Murayama Y, Giambarella U, et al. A novel system that reports the G-proteins linked to a given receptor: a study of type 3 somatostatin receptor [J]. FEBS Lett, 1997, 406(1-2): 165-170.
  • 6Patel YC. Somatoslatin and its receptor family [ J]. Front Neuroendocrinol, 1999, 20(3): 157-198.
  • 7Patel YC, Green wood MT, Panetta R, et al. The somatostatin receptor family [J]. Life Sci, 1995, 57( 13): 1249-1265.
  • 8Hu C, Yi C, Hao Z, et al. The effect of somatostatin and SSTR3 on proliferation and apoptosis of gastric cancer cells [ J]. Cancer Biol Ther, 2004, 3(8) : 726,:731.
  • 9Reuhi JC, Waser B, Schmassmann A, et al. Receptor autoradiographic evaluation of eholeeyestokinin, neurotension, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: where are they really located [ J] ? Int J Cancer, 1999, 81 (3) : 376-386.
  • 10颜登国,区庆嘉,李江涛.原发性肝癌生长抑素受体mRNA表达的研究[J].中华普通外科杂志,2003,18(1):55-56. 被引量:17

共引文献3

同被引文献23

  • 1Knut Magne Augestad,Conor P Delaney.Postoperative ileus: Impact of pharmacological treatment,laparoscopic surgery and enhanced recovery pathways[J].World Journal of Gastroenterology,2010,16(17):2067-2074. 被引量:34
  • 2SIVASANKARAN B, DEGEN M, GHAFFARI A, et al. Tena- scin-C is a novel RBPJ kappa-induced target gene for Notch signaling in gliomas [ J ]. Cancer Res, 2009,69 ( 2 ) : 458-465.
  • 3HASE K, SHATNEY C H, MOCHIZHKI H, et al. Long-term results of curative resection of' minimally invasive' colorectal cancer[ J]. Dis Colon Rectum, 1995,38( 1 ) : 19-26.
  • 4GUZINSKA-USTYMOWICZ KSULKOWSKA MFAMUESKI W et al. Tumour' budding'and its relationship to p53 and Bcl- 2 expression in colorectal cancer [ J ]. Anticaner Reserch, 2003, 23(IB) :649-654.
  • 5OKUYARMA T, OYA M, ISHIKAWA H. Budding as a useful prognostic marker in pT3 well-or moderately-differentiated rec- tal adenocareinoma[ J]. J Surg Oncol,2003,83( 1 ):42-47.
  • 6PRALL F, NIZZW H, BARTEN M. Tumor budding as prognos- tic factor in stage I / 1I coloreetal carcinoma [J]. Histopathol- ogy,2005,47 ( 1 ) : 17-24.
  • 7PARK K J, CHOI H J,ROH M S, et al. Intensity of tumor bud- ding and its prognostic implication in invasive colon carcinoma [ J ]. Dis Colon Rectum,2005, 48 ( 8 ) : 1597-1602.
  • 8SAITO Y, IMAZEKI H, MIURA S, et al. A peptide derived from tenascin-C induces beta 1 integrin activation through syn- decan-4[ J]. J Biol Chem,2007,282(48):34929-34957.
  • 9van OBBERGHEN-SCHILLING E,TUCKER R P,SAUPE F, et al. Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth [ J ]. Int J Dev Biol,2011,55(4-5) :511-525.
  • 10JAHKOLA T, TOIVONEN T, yon SMITI'EN K, et al. Expres- sion of tenascin in invasion border of early breast cancer cor- relates with higher risk of distant metastasis [ J ]. Int J Canc- er, 1996,69 (6) : 445- 447.

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部